![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
References
- Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157(5 Pt 1):1418-22
- Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003;124:459-67
- Soler-Cataluna JJ, Martinez-Garcia MA, Roman-Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-31
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2007
- World Health Organization. World Health Statistics, 2008. World Health Organization
- Miravitlles M, Anzueto A, Legnani D, et al. Patient's perception of exacerbations of COPD -- the PERCEIVE study. Respir Med 2007;101:453-60
- Haughney J, Partridge MR, Vogelmeier C, et al. Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling. Eur Respir J 2005;26:623-9
- Carrasco-Garrido P, de Miguel Diez J, Rejas-Gutierrez J, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes 2006;4:31
- Calverley PM, Lee A, Towse L, et al. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 2003;58:855-60
- van Noord JA, Aumann JL, Janssens E, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006;129:509-17
- McCarley C, Hanneman SK, Padhye, N, Smolensky, MA. A pilot home study of temporal variations of symptoms in chronic obstructive lung disease. Biol Res Nurs 2007;9:8-20
- Postma DS, Koeter GH, Mark TW, et al. The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest 1985;87:653-7
- Partridge MR, Karlsson N. Patient insights on the impact of morning symptoms of COPD. Sixth International Multidisciplinary Conference on COPD (COPD6). Birmingham, UK; 11-13 June 2008; Poster 11
- American Thoracic Society. Surveillance for respiratory hazards in the occupational setting. Am Rev Respir Dis 1982;126:952-6
- Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance – United States, 1971-2000. MMWR Surveill Summ 2002;51:1-16
- Adams PF, Hendershot GE, Marano MA; Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10 1999;(200):1-203
- Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008;63:402-7
- Pena VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981-9
- Biskobing DM. COPD and osteoporosis. Chest 2002;121:609-20
- Call-Schmidt TA, Richardson SJ. Prevalence of sleep disturbance and its relationship to pain in adults with chronic pain. Pain Manag Nurs 2003;4:124-33
- Menefee LA, Frank ED, Doghramji K, et al. Self-reported sleep quality and quality of life for individuals with chronic pain conditions. Clin J Pain 2000;16:290-7
- Marin R, Cyhan T, Miklos W. Sleep disturbance in patients with chronic low back pain. Am J Phys Med Rehabil 2006;85:430-5
- Marty M, Rozenberg S, Duplan B, et al. Quality of sleep in patients with chronic low back pain: a case-control study. Eur Spine J 2008;17:839-44